Skip to content
Open·Ingested 90 days ago, not re-verified since

DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy - Early-Career Investigator Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Posted
May 4, 2026
Amount
$4,200,000
Closes
Oct 1, 2026 (in 59 days)

Get alerted when new grant funding like this opens.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

Classification and identifiers

Solicitation number
HT942526OCRPOCCTAECI
Assistance listing (CFDA)
12.420

Amount

$4,200,000

Who can apply

Open to all

About this opportunity

Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for ovarian cancer. The OCCTA, through its Leadership, provides for professional and leadership development of the ECIs to include skills and competencies needed to execute clinical trials, providing intensive mentoring, national networking, collaborations, and a peer group for junior clinical trialists. The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly productive clinical trials in ovarian cancer. Distinctive Features: Research funded under th...

Refine this search